CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Voyager Therapeutics Expects to Start Early Alzheimer's Study in Adults in H2

Trial StartNeutral
AI Analysis

Summary

Voyager Therapeutics expects to initiate an early-stage Alzheimer's disease study in adults during the second half of 2026.

Clinical Trial Data

Phase

Early

Importance:4/10
Sentiment:
0.00
Alzheimer'sClinical TrialEarly StageGene Therapy
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 12:35 PM

Read Original